Immunogenic Epitopes Mapping of BB0108 and BB0323 Proteins from Borrelia burgdorferi Sensu Lato in the Context of Lyme Disease Diagnosis
ACS Infectious Diseases · 16.11.2026
DOI: 10.1021/acsinfecdis.6c00506 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 16.11.2026. Verfasst von Alberto Moraga-Fernández und 4 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovaci?n y Universidades, European Regional Development Fund, Narodowe Centrum Nauki.
Abstract (Originalsprache)
Lyme borreliosis (LB) is an emerging tick-borne zoonosis in Europe, transmitted primarily by Ixodes ricinus and Ixodes persulcatus. The causative agent, Borrelia burgdorferi sensu lato (s.l.), comprises approximately 20 genospecies, of which five are responsible for human infection in Europe: Borrelia afzelii, Borrelia garinii, B. burgdorferi sensu stricto (s.s.), Borrelia bavariensis, and Borrelia spielmanii. Due to limitations in direct pathogen detection, LB diagnosis relies mainly on serological assays. However, cross-reactive antibodies can compromise both specificity and sensitivity, highlighting the need for more specific antigenic targets and improved diagnostic strategies beyond conventional two-tier approaches. Epitope mapping represents a promising strategy to identify highly specific immunoreactive regions and reduce cross-reactivity. In this study, we identified immunoreactive peptides to improve LB serodiagnosis. Linear B-cell epitopes were mapped using peptide microarrays across three major European genospecies (B. afzelii, B. burgdorferi s.s., and B. garinii), revealing regions reactive to IgG, IgM, or both. Selected IgG peptides showed sensitivities of 81.6–92.1% and specificities of 92.1–94.7%, whereas IgM peptides exhibited sensitivities of 77.8–94.4% and specificities of 94.6–97.3%. A chimeric protein designed for IgG detection achieved a sensitivity of 94.7% and a specificity of 97.4%. These findings demonstrate that epitope-based antigen design and chimeric constructs can enhance the accuracy of LB serodiagnosis.
Förderung
- Ministerio de Ciencia, Innovaci?n y Universidades
- European Regional Development Fund
- Narodowe Centrum Nauki
- Ministerio de Ciencia, Tecnolog?a e Innovaci?n
- NextGenerationEU
Zitieren
APA
Moraga-Fernández, A., Holec-Gąsior, L., Grąźlewska, W., Fernández-Melgar, R., & Contreras, M. (2026). Immunogenic Epitopes Mapping of BB0108 and BB0323 Proteins from Borrelia burgdorferi Sensu Lato in the Context of Lyme Disease Diagnosis. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.6c00506
Vancouver
Moraga-Fernández A, Holec-Gąsior L, Grąźlewska W, Fernández-Melgar R, Contreras M. Immunogenic Epitopes Mapping of BB0108 and BB0323 Proteins from Borrelia burgdorferi Sensu Lato in the Context of Lyme Disease Diagnosis. ACS Infectious Diseases. 2026. doi:10.1021/acsinfecdis.6c00506
BibTeX
@article{MoragaFernandez2026,
author = {Moraga-Fernández, Alberto and Holec-Gąsior, Lucyna and Grąźlewska, Weronika and Fernández-Melgar, Rubén and Contreras, Marinela},
title = {Immunogenic Epitopes Mapping of BB0108 and BB0323 Proteins from Borrelia burgdorferi Sensu Lato in the Context of Lyme Disease Diagnosis},
journal = {ACS Infectious Diseases},
year = {2026},
doi = {10.1021/acsinfecdis.6c00506}
}
EUVIMED